Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy

Kazufumi Nakamura1, Kengo Fukushima Kusano, Hiromi Matsubara

  • 1Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.

Journal of Cardiac Failure
|February 26, 2005
PubMed

Insights

Oxidative stress is elevated in hypertrophic cardiomyopathy (HCM) patients, contributing to heart failure. Elevated levels correlate with left ventricular dilatation and reduced systolic function in HCM.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pathophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) can progress to left ventricular dilatation and systolic dysfunction.
  • The underlying mechanisms driving this progression remain unclear.
  • This study investigates the role of oxidative stress in HCM progression.

Purpose of the Study:

  • To determine if oxidative stress is elevated in the myocardium of HCM patients.
  • To assess the correlation between oxidative stress levels and left ventricular dilatation and systolic dysfunction in HCM.

Main Methods:

  • Immunohistochemical analysis of endomyocardial biopsy samples from 31 HCM patients and 10 controls.
  • Quantification of 4-hydroxy-2-nonenal (HNE)-modified protein, a marker of lipid peroxidation.
  • Correlation analysis with echocardiographic and ventriculographic measurements.

Main Results:

  • HNE-modified protein expression was significantly increased in HCM patients compared to controls (P = .0005).
  • Expression levels correlated positively with left ventricular end-diastolic diameter (r = 0.483) and end-systolic diameter (r = 0.500).
  • Expression levels showed an inverse correlation with left ventricular ejection fraction (r = -0.640).

Conclusions:

  • Oxidative stress is elevated in the myocardium of HCM patients.
  • Elevated oxidative stress is associated with left ventricular dilatation and systolic dysfunction in HCM.
  • Oxidative stress plays a role in the pathogenesis of heart failure in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...